Collagen triple helix repeat containing 1
Collagen triple helix repeat containing 1 is a protein that in humans is encoded by the CTHRC1 gene. [1]
Function
Function
This locus encodes a protein that may play a role in the cellular response to arterial injury through involvement in vascular remodeling. Mutations at this locus have been associated with Barrett esophagus and esophageal adenocarcinoma. Alternatively, spliced transcript variants have been described.
References
References
- ↑ “Entrez Gene: Collagen triple helix repeat containing 1”. Retrieved 2017-07-25.
Further reading
Further reading
- Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, Friesel RE, Lindner V (2005). “Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration”. Circ. Res. 96 (2): 261–8. doi:10.1161/01.RES.0000154262.07264.12. PMID 15618538.
- Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y (2006). “Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers”. Clin. Cancer Res. 12 (12): 3716–22. doi:10.1158/1078-0432.CCR-06-0030. PMID 16778098.
- Leclair RJ, Wang Q, Benson MA, Prudovsky I, Lindner V (2008). “Intracellular localization of Cthrc1 characterizes differentiated smooth muscle”. Arterioscler. Thromb. Vasc. Biol. 28 (7): 1332–8. doi:10.1161/ATVBAHA.108.166579. PMC 3508505.
- Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Pérez L, Schiavi F, Leskelä S, Pita G, Milne R, Maravall J, Ramos I, Andía V, Rodríguez-Poyo P, Jara-Albarrán A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Picó A, Pomares F, Giménez G, López-Mondéjar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodríguez-Antona C, González-Neira A, Matías-Guiu X, Santisteban P, Robledo M (2009). “The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors”. PLoS Genet. 5 (9): e1000637. doi:10.1371/journal.pgen.1000637. PMC 2727793. PMID 19730683.
- Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, David S, Cheng Y, Meltzer SJ, Eng C (2011). “Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma”. JAMA. 306 (4): 410–9. doi:10.1001/jama.2011.1029. PMC 3574553. PMID 21791690.
- Wang P, Wang YC, Chen XY, Shen ZY, Cao H, Zhang YJ, Yu J, Zhu JD, Lu YY, Fang JY (2012). “CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer”. Cancer Sci. 103 (7): 1327–33. doi:10.1111/j.1349-7006.2012.02292.x. PMID 22590977.
- Park EH, Kim S, Jo JY, Kim SJ, Hwang Y, Kim JM, Song SY, Lee DK, Koh SS (2013). “Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells”. Carcinogenesis. 34 (3): 694–702. doi:10.1093/carcin/bgs378. PMID 23222813.
- Spector I, Zilberstein Y, Lavy A, Genin O, Barzilai-Tutsch H, Bodanovsky A, Halevy O, Pines M (2013). “The involvement of collagen triple helix repeat containing 1 in muscular dystrophies”. Am. J. Pathol. 182 (3): 905–16. doi:10.1016/j.ajpath.2012.11.004. PMID 23274062.
- Tan F, Liu F, Liu H, Hu Y, Liu D, Li G (2013). “CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis”. Med. Oncol. 30 (1): 473. doi:10.1007/s12032-013-0473-3. PMID 23359115.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH